Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin Wood

Showing results (261-270 of 369) with videos related to

Pageof 37
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 5, 2011
Comparison of the early fungicidal activity of high-dose fluconazole, voriconazole, and flucytosine as second-line drugs given in combination with amphotericin B for the treatment of HIV-associated cryptococcal meningitisAngela Loyse, Douglas Wilson, Graeme Meintjes, et al.
AIDS (London, England)|April 20, 2004
Evaluation of nevirapine and/or hydroxyurea with nucleoside reverse transcriptase inhibitors in treatment-naive HIV-1-infected subjectsDaniel H Blanckenberg, Robin Wood, Andrzej Horban, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 30, 2012
Tenofovir in second-line ART in Zambia and South Africa: collaborative analysis of cohort studiesGilles Wandeler, Olivia Keiser, Lloyd Mulenga, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Within-country heterogeneity in patterns of social contact relevant for tuberculosis infection transmission, prevention, and careKate E LeGrand, Anita Edwards, Mbali Mohlamonyane, et al.
The Pediatric Infectious Disease Journal|November 15, 2019
Earlier Antiretroviral Therapy Initiation and Decreasing Mortality Among HIV-infected Infants Initiating Antiretroviral Therapy Within 3 Months of Age in South Africa, 2006-2017Victoria Iyun, Karl-Gunter Technau, Brian Eley, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 12, 2010
The clinical impact and cost-effectiveness of routine, voluntary HIV screening in South AfricaRochelle P Walensky, Robin Wood, Mariam O Fofana, et al.
AIDS (London, England)|December 4, 2002
Time-dependent changes in HIV nucleoside analogue phosphorylation and the effect of hydroxyureaPatrick G Hoggard, Stephen Kewn, Anlie Maherbe, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2012
Frequent emergence of N348I in HIV-1 subtype C reverse transcriptase with failure of initial therapy reduces susceptibility to reverse-transcriptase inhibitorsJessica H Brehm, Dianna L Koontz, Carole L Wallis, et al.
Annals of Internal Medicine|April 2, 2019
Risks and Benefits of Dolutegravir- and Efavirenz-Based Strategies for South African Women With HIV of Child-Bearing Potential: A Modeling StudyCaitlin M Dugdale, Andrea L Ciaranello, Linda-Gail Bekker, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 5, 2012
The cost-effectiveness of pre-exposure prophylaxis for HIV infection in South African womenRochelle P Walensky, Ji-Eun Park, Robin Wood, et al.
Pageof 37

Showing results (261-270 of 369) with videos related to

Sort By:
Pageof 37
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 5, 2011
Comparison of the early fungicidal activity of high-dose fluconazole, voriconazole, and flucytosine as second-line drugs given in combination with amphotericin B for the treatment of HIV-associated cryptococcal meningitisAngela Loyse, Douglas Wilson, Graeme Meintjes, et al.
AIDS (London, England)|April 20, 2004
Evaluation of nevirapine and/or hydroxyurea with nucleoside reverse transcriptase inhibitors in treatment-naive HIV-1-infected subjectsDaniel H Blanckenberg, Robin Wood, Andrzej Horban, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 30, 2012
Tenofovir in second-line ART in Zambia and South Africa: collaborative analysis of cohort studiesGilles Wandeler, Olivia Keiser, Lloyd Mulenga, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Within-country heterogeneity in patterns of social contact relevant for tuberculosis infection transmission, prevention, and careKate E LeGrand, Anita Edwards, Mbali Mohlamonyane, et al.
The Pediatric Infectious Disease Journal|November 15, 2019
Earlier Antiretroviral Therapy Initiation and Decreasing Mortality Among HIV-infected Infants Initiating Antiretroviral Therapy Within 3 Months of Age in South Africa, 2006-2017Victoria Iyun, Karl-Gunter Technau, Brian Eley, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 12, 2010
The clinical impact and cost-effectiveness of routine, voluntary HIV screening in South AfricaRochelle P Walensky, Robin Wood, Mariam O Fofana, et al.
AIDS (London, England)|December 4, 2002
Time-dependent changes in HIV nucleoside analogue phosphorylation and the effect of hydroxyureaPatrick G Hoggard, Stephen Kewn, Anlie Maherbe, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2012
Frequent emergence of N348I in HIV-1 subtype C reverse transcriptase with failure of initial therapy reduces susceptibility to reverse-transcriptase inhibitorsJessica H Brehm, Dianna L Koontz, Carole L Wallis, et al.
Annals of Internal Medicine|April 2, 2019
Risks and Benefits of Dolutegravir- and Efavirenz-Based Strategies for South African Women With HIV of Child-Bearing Potential: A Modeling StudyCaitlin M Dugdale, Andrea L Ciaranello, Linda-Gail Bekker, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 5, 2012
The cost-effectiveness of pre-exposure prophylaxis for HIV infection in South African womenRochelle P Walensky, Ji-Eun Park, Robin Wood, et al.
Pageof 37